Andrew Peter Turnbull
Presidente presso Nanolayr Ltd.
Profilo
Andrew Peter Turnbull is currently the Chairman of Nanolayr Ltd.
and a Director at Lypanosys (NZ) Ltd., Lypanosys Pte Ltd., and Kayasand Holdings Ltd.
He was formerly a Director of Business Development at Allergy Therapeutics Plc.
Turnbull received an undergraduate degree from the University of Canterbury.
Posizioni attive di Andrew Peter Turnbull
Società | Posizione | Inizio |
---|---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Direttore/Membro del Consiglio | 30/03/2009 |
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Direttore/Membro del Consiglio | 06/06/2011 |
Kayasand Holdings Ltd.
Kayasand Holdings Ltd. Construction MaterialsNon-Energy Minerals Kayasand Holdings Ltd. engages in the manufacture of cement. The company was founded by Christoph Sattler on September 12, 2014 and is headquartered in Matamata, New Zealand. | Direttore/Membro del Consiglio | - |
Nanolayr Ltd.
Nanolayr Ltd. Miscellaneous Commercial ServicesCommercial Services Nanolayr Ltd. offers electrospinning proces to create custom-made nanofibre materials. The firm’s products have many applications, including filtration, cosmetics, healthcare, composites and electronics. The company was founded by Simon Vaughn Feasey, Michael John Perrett and Iain Cameron Hosie in 2009 and is headquartered in Henderson, New Zealand. | Presidente | 01/10/2019 |
Precedenti posizioni note di Andrew Peter Turnbull
Società | Posizione | Fine |
---|---|---|
ALLERGY THERAPEUTICS PLC | Corporate Officer/Principal | 31/12/2005 |
Formazione di Andrew Peter Turnbull
University of Canterbury | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALLERGY THERAPEUTICS PLC | Health Technology |
Aziende private | 4 |
---|---|
Lypanosys (NZ) Ltd.
Lypanosys (NZ) Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys (NZ) Ltd. engages in the manufacture of pharmaceutical products. The company was founded on December 20, 2007 and is headquartered in Auckland, New Zealand. | Health Technology |
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
Kayasand Holdings Ltd.
Kayasand Holdings Ltd. Construction MaterialsNon-Energy Minerals Kayasand Holdings Ltd. engages in the manufacture of cement. The company was founded by Christoph Sattler on September 12, 2014 and is headquartered in Matamata, New Zealand. | Non-Energy Minerals |
Nanolayr Ltd.
Nanolayr Ltd. Miscellaneous Commercial ServicesCommercial Services Nanolayr Ltd. offers electrospinning proces to create custom-made nanofibre materials. The firm’s products have many applications, including filtration, cosmetics, healthcare, composites and electronics. The company was founded by Simon Vaughn Feasey, Michael John Perrett and Iain Cameron Hosie in 2009 and is headquartered in Henderson, New Zealand. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Peter Turnbull